Clinical Trials on Influenza A in South Africa
Total 534 results
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
BioCryst PharmaceuticalsCompletedInfluenzaUnited States, Canada
-
Hoffmann-La RocheTerminated
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Myxovirus Infection | Orthomyxovirus InfectionUnited States
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis IVA (Morquio A Syndrome)Australia
-
Kirby InstituteCompleted
-
Hoffmann-La RocheCompletedHemophilia AUnited States, Korea, Republic of, Italy, South Africa, Spain, China, Japan, Poland, Australia, Costa Rica, Germany, Taiwan
-
Catalyst BiosciencesCompletedHemophilia AUnited States, Belgium, Hungary, Italy, New Zealand, South Africa, Turkey, United Kingdom
-
Kirby InstituteCompleted
-
Novo Nordisk A/SRecruitingHaemophilia A With or Without InhibitorsKorea, Republic of, India, China, Canada, Spain, Netherlands, South Africa, United States, Israel, Japan, Poland, United Kingdom, Italy, Lithuania, Portugal, Switzerland, Taiwan
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, United Kingdom, Spain, Hong Kong, Israel, New Zealand, Sweden, Australia, Brazil, Japan, Austria, Belgium, Italy, India, Switzerland, Canada, France, Germany, South Africa
-
Kirby InstituteRecruitingHepatitis C | Liver Cirrhoses | Liver InflammationAustralia
-
BioCryst PharmaceuticalsTerminated
-
Gordon BernardTerminatedInfluenza | Acute Respiratory Distress Syndrome | H1N1 InfluenzaUnited States
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AKorea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
-
Kirby InstituteCompleted
-
Kirby InstituteCompleted
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedHemophilia ANetherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
-
Catalyst BiosciencesTerminatedHemophilia A With Inhibitor | Hemophilia B With InhibitorUnited States, United Kingdom, Taiwan, Italy, Spain, India, Turkey, Malaysia, Russian Federation, Armenia, Georgia, Hungary, Mexico, Poland, South Africa, Ukraine
-
BioCryst PharmaceuticalsDepartment of Health and Human ServicesCompletedFatigue | Myalgia | Cough | Headache | Nasal Congestion | Seasonal Influenza | Sore ThroatUnited States, Mexico, Canada, Australia, New Zealand, Puerto Rico
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia ATaiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, Portugal, Lithuania, Turkey, China, South Africa, Ireland, Italy, France, Japan, Belgium, Germany, Malaysia, Poland, Austria, Bulgaria, Denmark and more
-
Kirby InstituteTerminatedHepatitis CAustralia
-
Kirby InstituteWithdrawn
-
GlaxoSmithKlineCompletedInfluenzaFrance, Germany, United States, Taiwan, Estonia, Poland, Canada, Romania, Russian Federation, Belgium, United Kingdom, Netherlands, Norway, Mexico, Czechia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Sweden, Serbia, Turkey, United Kingdom, Malaysia, Brazil, Former Serbia and Montenegro, Japan, South Africa
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
SeqirusCompletedInfluenza, HumanBangladesh, Bulgaria, Czechia, Estonia, Honduras, Latvia, Malaysia, New Zealand, Pakistan, Philippines, Poland, Romania, Thailand, Ukraine, South Africa
-
ModernaTX, Inc.Active, not recruitingInfluenza | SARS-CoV-2United States
-
MDVI, LLCMediVector, Inc.CompletedInfluenzaUnited States, Canada, Brazil, Mexico, Colombia, Argentina, Peru, Puerto Rico, Guatemala, Dominican Republic, El Salvador
-
GlaxoSmithKlineCompletedHepatitis B | Hepatitis AAustralia
-
Kirby InstituteRecruitingHepatitis BAustralia
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia AUnited States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
-
Kirby InstituteRecruiting
-
CSL BehringCompletedHemophilia A | Severe Hemophilia AUnited States, Australia, Austria, Canada, Czechia, France, Georgia, Germany, Hungary, Ireland, Italy, Japan, Lebanon, Malaysia, Netherlands, Philippines, Poland, Portugal, Romania, South Africa, Spain, Switzerland, Thailand, Ukraine, United...
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Orthomyxoviridae Infection | Myxovirus InfectionUnited States, Puerto Rico
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia AUnited States, Poland, United Kingdom, Netherlands, South Africa, Hong Kong, Australia, Ireland
-
Kirby InstituteCompleted
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
GlaxoSmithKlineCompletedHepatitis BAustralia, Belgium
-
GlaxoSmithKlineCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedCommunicable Diseases | Hepatitis B | HIV | Infectious Diseases | HBVUnited Kingdom
-
Kirby InstituteCompleted
-
BioNTech SEPfizerRecruiting
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Kirby InstituteNational Institutes of Health (NIH); The University of New South WalesCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Whooping Cough | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type bColombia, Costa Rica
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Macfarlane Burnet Institute for Medical Research...Recruiting